Prophylactic antiemetic effects of Ondansetron and Haloperidol patients undergoing mastectomy- double-blind clinical trial
Phase 3
Recruiting
- Conditions
- Mastectomy surgery.
- Registration Number
- IRCT20240224061097N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
All candidate patients for bilateral mastectomy 2 side
ASA class 1 and 2 patients
All patients with general anesthesia
Patients aged 35-60.
Exclusion Criteria
Duration of surgery more than 150 minutes
Parkinson's disease
Patients with a history of psychiatric disorders
History of chemotherapy and radiation therapy
History of nausea and vomiting in previous surgeries
Having a movement disorder patient with a history of malignancy
Patients with prolonged QT interval
Use of opioids, sedatives, or any type of analgesic within one week before mastectomy History of alcohol consumption
History of drug abuse
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method